Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Thymus-derived (natural) CD4+ FoxP3+ regulatory T cells (nT reg cells) are required for immune homeostasis and self-tolerance, but must be stringently controlled to permit expansion of protective immunity. Previous findings linking signals transmitted through T cell–expressed C5a receptor (C5aR) and C3a receptor (C3aR) to activation, differentiation, and expansion of conventional CD4+CD25− T cells (T conv cells), raised the possibility that C3aR/C5aR signaling on nT reg cells could physiologically modulate nT reg cell function and thereby further impact the induced strength of T cell immune responses. In this study, we demonstrate that nT reg cells express C3aR and C5aR, and that signaling through these receptors inhibits nT reg cell function. Genetic and pharmacological blockade of C3aR/C5aR signal transduction in nT reg cells augments in vitro and in vivo suppression, abrogates autoimmune colitis, and prolongs allogeneic skin graft survival. Mechanisms involve C3a/C5a-induced phosphorylation of AKT and, as a consequence, phosphorylation of the transcription factor Foxo1, which results in lowered nT reg cell Foxp3 expression. The documentation that C3a/C3aR and C5a/C5aR modulate nT reg cell function via controlling Foxp3 expression suggests targeting this pathway could be exploited to manipulate pathogenic or protective T cell responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In particular, complement may reduce Treg function (20, 21) and promote T and B cell activation (22, 23).”
From Pre-existing humoral immunity and complement pathway contribute to immunogenicity of adeno-associated virus (AAV) vector in human blood (2022) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Radhakrishnan, S., Cabrera, R., Schenk, E. L., Nava-Parada, P., Bell, M. P., Van Keulen, V. P., Marler, R. J., Felts, S. J., & Pease, L. R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3137 · Cited by 111 · cited 2×
“…signals via these mechanisms can potentially overcome selftolerance, resulting in pathogenic autoimmu nity (André et al., 2009; Bettini and Vignali, 2009; O’Sullivan et al., 2006; Radhakrishnan et al., 2008) and prevention of transplant tolerance (Chen et al., 2009; Porrett et al., 2008).”
BackgroundRetractedControl of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
CTLA-4 Control over Foxp3 + Regulatory T Cell Function
Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T., & Sakaguchi, S. (2008) · Science · doi:10.1126/science.1160062 · Cited by 2,956 · cited 4×
“2, D and E), one molecule through which nT reg cells are known to me diate their suppressive function (Wing et al., 2008).”
BackgroundInfluentialAn essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856 · cited 3×
“Reconstituting Foxp3 expression rescues suppressive capacity, and adoptive transfer of Foxp3+CD4+ T cells into Foxp3deficient animals rescues selftolerance (Fontenot et al., 2003, 2005; Hori et al., 2003; Khattri et al., 2003).”
BackgroundInfluentialRegulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3
Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., & Rudensky, A. Y. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.016 · Cited by 2,279 · cited 5×
“…function in vitro To address whether and how immune cell–derived C3a and/ or C5a impact nT reg cells we performed RTPCR assays on flowsorted, peripheral, CD4+Foxp3+GFP+ nT reg cells obtained from Foxp3GFP reporter mice (Fontenot et al., 2005) before and after stimulation with antiCD3/CD28 (Fig.”
BackgroundMethodInfluentialRead, S., Malmström, V., & Powrie, F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.295 · Cited by 2,205
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
Pasare, C., & Medzhitov, R. (2003) · Science · doi:10.1126/science.1078231 · Cited by 1,997 · cited 4×
“Several groups showed that TLRstimulated APCs upregulate IL6, IL1, and complement protein production, coincident with inhib iting T reg cell function (Pasare and Medzhitov, 2003; Hu et al., 2011; Peng et al., 2006; Zhou et al., 2006), and that the IL6–mediated effects are linked to C5aR in other cell types (Ried…”
BackgroundMethodInfluentialZhou, X., Bailey-Bucktrout, S. L., Jeker, L. T., Penaranda, C., Martínez-Llordella, M., Ashby, M., Nakayama, M., Rosenthal, W., & Bluestone, J. A. (2009) · Nature Immunology · doi:10.1038/ni.1774 · Cited by 1,370 · cited 1×
“…that pro inflammatory signals can limit the function of circulating, predominantly nT reg cells by blocking or downregulating Foxp3 expression (Degauque et al., 2008; Rubtsov et al., 2010; Zhou et al., 2009a,b), particularly within a CD25lo subset of the Foxp3+ T reg cells (Miyao et al., 2012).”
BackgroundMolecular Antagonism and Plasticity of Regulatory and Inflammatory T Cell Programs
Yang, X. O., Nurieva, R., Martinez, G. J., Kang, H. S., Chung, Y., Pappu, B. P., Shah, B., Chang, S. H., Schluns, K. S., Watowich, S. S., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.05.007 · Cited by 1,136 · cited 2×
“Signals trans mitted by these molecules to T reg cells inhibit or limit Foxp3 expression, preferentially yielding Th1 and/or Th17 effector cells which facilitate expansion of pathogenreactive T cell responses (Yang et al., 2008).”
Background
Cited by
Items 101–200 of 215
Mathern, D. R., Horwitz, J. K., & Heeger, P. S. (2018) · American Journal of Transplantation · doi:10.1111/ajt.15222 · Cited by 30
Self-citationHan, J., & Zhang, X. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.653293 · Cited by 31
“Further studies confirmed that increasing the intracellular expression of C3a in T cells can significantly prolong their survival (77, 78).”
BackgroundUpdate on Immune Mechanisms in Hypertension
Navaneethabalakrishnan, S., Smith, H., Arenaz, C. M., Goodlett, B. L., McDermott, J. G., & Mitchell, B. M. (2022) · American Journal of Hypertension · doi:10.1093/ajh/hpac077 · Cited by 39
Complement Activation in Progression of Chronic Kidney Disease
Chen, S., & Chen, M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-8871-2_20 · Cited by 30
Hu, X., Li, X., Hu, C., Qin, L., He, R., Luo, L., Tang, W. F., & Feng, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-15471-w · Cited by 26
Distinct Roles of the Anaphylatoxins C3a and C5a in Dendritic Cell–Mediated Allergic Asthma
Engelke, C., Wiese, A. V., Schmudde, I., Ender, F., Ströver, H. A., Vollbrandt, T., König, P., Laumonnier, Y., & Köhl, J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400080 · Cited by 27
Verghese, D. A., Demir, M., Chun, N. H., Fribourg, M., Cravedi, P., Llaudó, I., Woodruff, T. M., Yadav, P. D., Lira, S. A., Medof, M. E., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701638 · Cited by 28
“human and murine thymic-derived TREG function (19), as well as iTREG generation, function, and stability (18–20).”
BackgroundSelf-citationUnexpected Roles for Intracellular Complement in the Regulation of Th1 Responses
West, E. E., Afzali, B., & Kemper, C. (2018) · Advances in immunology · doi:10.1016/bs.ai.2018.02.001 · Cited by 27
Innate immunity in solid organ transplantation: an update and therapeutic opportunities
Béland, S., Désy, O., Vallin, P., Basoni, C., & Serres, S. A. D. (2015) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2015.1008453 · Cited by 24
“C5a and C3a directly transmit signals to T cells via C5a and C3a receptors responses, which in turn modulate natural Treg function [91].”
BackgroundYamanaka, K., Kakuta, Y., Miyagawa, S., Nakazawa, S., Kato, T., Abe, T., Imamura, R., Okumi, M., Maeda, A., Okuyama, H., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148881 · Cited by 26
“Antagonism of the C3a receptor (C3aR) can also induce functional changes and induce the production of regulatory T cells [9, 10].”
BackgroundKhan, M. A., Alanazi, F., Ahmed, H. A., Vater, A., Assiri, A. M., & Broering, D. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01010 · Cited by 26
“It is known that complement activation and signaling through C3aR and C5aR suppress regulatory functions of murine natural regulatory T cells through FOXP3 expression (11).”
BackgroundParsons, N., Annamalai, B., Obert, E., Schnabolk, G., Tomlinson, S., & Rohrer, B. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.02.001 · Cited by 25
“C57BL/6J and C3aR/C5aR double-deficient mice (C3aR−/− C5aR−/−) on a C57BL/6J background (Kwan et al., 2013) were randomly assigned to different treatment groups, and CNV lesions induced as described previously, using argon laser photocoagulation (532 nm, 100 μm spot size, 0.”
MethodPathogenic roles of anti-C1q antibodies in recurrent pregnancy loss
Ohmura, K., Oku, K., Kitaori, T., Amengual, O., Hisada, R., Kanda, M., Shimizu, Y., Fujieda, Y., Kato, M., Bohgaki, T., et al. (2019) · Clinical Immunology · doi:10.1016/j.clim.2019.04.005 · Cited by 25
Freiwald, T., & Afzali, B. (2021) · Advances in immunology · doi:10.1016/bs.ai.2021.09.001 · Cited by 27
Kong, L., Chen, X.-H., Sun, Q., Zhang, K., Xu, L., Ding, L., Zhou, Y., Zhang, Z.-B., Lin, J., & Gao, P. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112078 · Cited by 25
Ender, F., Wiese, A. V., Schmudde, I., Sun, J., Vollbrandt, T., König, P., Laumonnier, Y., & Köhl, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172446 · Cited by 24
C5aR and C5L2 act in concert to balance immunometabolism in adipose tissue
Poursharifi, P., Lapointe, M., Fisette, A., Lü, H., Roy, C., Munkonda, M. N., Fairlie, D. P., & Cianflone, K. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.10.019 · Cited by 23
“C5a, on the other hand, is a well-appreciated immune mediator, possessing regulatory roles in sepsis and other immunoinflammatory disorders (Fonseca et al., 2009; Grailer et al., 2013; Kwan et al., 2013; Li et al., 2012; Rittirsch et al., 2008).”
BackgroundA Novel Approach for Treatment of Cold Agglutinin Syndrome-Related Severe Hemolysis
Tesfaye, A. A., & Broome, C. M. (2016) · Journal of Hematology · doi:10.14740/jh242w · Cited by 23
“Regulatory T-cell generation, stability, and suppressive function are decreased by C3a and C5a signaling [14].”
BackgroundProtease Activated Receptor 4 as a Novel Modulator of Regulatory T Cell Function
Peng, Q., Ratnasothy, K., Boardman, D. A., Jacob, J., Tung, S. L., McCluskey, D., Smyth, L. A., Lechler, R. I., Dorling, A., & Lombardi, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01311 · Cited by 21
“Various molecular signals are capable of manipulating the function of Tregs including signaling through innate receptors such as Toll like receptors (TLRs) (9, 10) and anaphylatoxin receptors (C3aR/C5aR) (11, 12).”
BackgroundWashburn, R. L., & Dufour, J. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043371 · Cited by 20
Targeting complement C5a to improve radiotherapy sensitivity in non-small cell lung cancer
Yuan, M., Wang, C., Wu, Y., Qiao, L., Deng, G., Liang, N., Chen, F., Liu, L.-Z., Chen, Y., Yang, Y., et al. (2023) · Translational Lung Cancer Research · doi:10.21037/tlcr-23-258 · Cited by 21
“C3a and C5a combined with C3aR and C5aR have been clarified to mediate T-cell induction and inhibit Treg function (55,56).”
BackgroundEosinophils Are Not Required for the Induction and Maintenance of an Alloantibody Response
Cravedi, P., Lessman, D., & Heeger, P. S. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12404 · Cited by 20
Self-citationChaouat, G. (2015) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2015.09.002 · Cited by 20
Complement and Transplantation
Horwitz, J. K., Chun, N. H., & Heeger, P. S. (2018) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2018.10.004 · Cited by 21
Self-citationThe Complement System in Ovarian Cancer: An Underexplored Old Path
Senent, Y., Ajona, D., González-Martín, A., Pío, R., & Tavira, B. (2021) · Cancers · doi:10.3390/cancers13153806 · Cited by 25
“signaling promote the activation [90] and expansion [91] of T cells and divert their differentiation from Treg cells [92,93].”
BackgroundComplement‐mediated immune mechanisms in allergy
Laumonnier, Y., Korkmaz, R. Ü., Nowacka, A. A., & Köhl, J. (2023) · European Journal of Immunology · doi:10.1002/eji.202249979 · Cited by 24
Brummelman, J., Raeven, R. H. M., Helm, K., Pennings, J. L. A., Metz, B., van Eden, W., van Els, C. A. C. M., & Han, W. G. H. (2016) · Scientific Reports · doi:10.1038/srep25064 · Cited by 19
Liu, Y., Lu, H., Zhang, C., Hu, J., & Xu, D. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.01.005 · Cited by 20
CD55 Is Essential for CD103+ Dendritic Cell Tolerogenic Responses that Protect against Autoimmunity
Strainic, M. G., Liu, J., An, F., Bailey, E., Esposito, A., Hamann, J., Heeger, P. S., & Medof, M. E. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.04.008 · Cited by 22
Self-citationFreeley, S. J., Popat, R. J., Parmar, K., Kolev, M. V., Hunt, B. J., Stover, C. M., Schwaeble, W., Kemper, C., & Robson, M. G. (2016) · The Journal of Pathology · doi:10.1002/path.4754 · Cited by 18
Complement factor and T-cell interactions during alloimmune inflammation in transplantation
Khan, M. A., & Shamma, T. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.5ru0718-288r · Cited by 19
Old game, new players: Linking classical theories to new trends in transplant immunology
da Silva, M. B., da Cunha, F. F., Terra, F. F., & Câmara, N. O. S. (2017) · World Journal of Transplantation · doi:10.5500/wjt.v7.i1.1 · Cited by 19
Anaphylatoxins in organ transplantation
Li, K., & Zhou, W. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.04.013 · Cited by 16
Čumpelik, A., Cody, E., Yu, S. M.-W., Grasset, E. K., Dominguez-Sola, D., Cerutti, A., & Heeger, P. S. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200410 · Cited by 16
Self-citationDown-Regulation of C3aR/C5aR Inhibits Cell Proliferation and EMT in Hepatocellular Carcinoma
Chen, B., Zhou, W., Tang, C., Wang, G., Yuan, P., Zhang, Y., Bhushan, S. C., Ma, J., & Leng, J. (2020) · Technology in Cancer Research & Treatment · doi:10.1177/1533033820970668 · Cited by 16
“of allogeneic skin graft.(13,14) Interestingly, Wang et al reported that C3aR and C5aR could be targeted for cancer immunotherapy by exerting as a new class of immune checkpoint receptors.”
BackgroundImmune Regulatory Crosstalk in Adipose Tissue Thermogenesis
Yildiz, R., Ganbold, K., Sparman, N. Z. R., & Rajbhandari, P. (2025) · Comprehensive physiology · doi:10.1002/cph4.70001 · Cited by 17
“Previous studies have demonstrated that signaling through C3a/ C3aR and C5a/C5aR downregulates Foxp3 expression in Tregs, thereby inhibiting their immune-suppressive capabilities (Kwan et al. 2013).”
Fan, Y., Wang, Y., Yu, S., Chang, J. B. P., Yan, Y., Wang, Y., & Bian, Y. (2021) · Chinese Medicine · doi:10.1186/s13020-021-00478-3 · Cited by 16
“The complement is thought to be cross-related with neutrophil-mediated C5a receptor/tissue factor [99].”
BackgroundInfluentialComplement—here, there and everywhere, but what about the transplanted organ?
Montero, R., Sacks, S. H., & Smith, R. A. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.04.007 · Cited by 15
“Complement is known to regulate Tregs via signalling through C3aR and CD88 resulting in inhibition of Treg function [81].”
Wang, C., Cao, S., Zhang, D., Li, H., Kijlstra, A., & Yang, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-15740-8 · Cited by 20
Targeting of G-protein coupled receptors in sepsis
Rehman, A., Baloch, N. U.-A., Morrow, J., Pacher, P., & Haskó, G. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107529 · Cited by 20
Immune response and histology of humoral rejection in kidney transplantation
González-Molina, M., Esteban, P. R., Caballero, A., Burgos, D., Cabello, M., Leon, M., Fuentes, L., & Hernández, D. (2016) · Nefrología · doi:10.1016/j.nefro.2016.03.023 · Cited by 20
Complement activation and kidney transplantation; a complex relationship
Gibson, B. G., Connelly, C., Moldakhmetova, S., & Sheerin, N. (2023) · Immunobiology · doi:10.1016/j.imbio.2023.152396 · Cited by 15
Complement’s involvement in allergic Th2 immunity: a cross-barrier perspective
Thomas, S. A., & Lajoie, S. (2025) · Journal of Clinical Investigation · doi:10.1172/jci188352 · Cited by 15
“C3a and C5a have been identified as negative regulators of mouse and human Treg function (128, 129).”
Complement in Non-Antibody-Mediated Kidney Diseases
Angeletti, A., Reyes‐Bahamonde, J., Cravedi, P., & Campbell, K. N. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00099 · Cited by 15
“Peripheral, murine, natural regulatory T cells (nTregs) express C3aR and C5aR and signaling through these receptors inhibits Treg function (15).”
BackgroundThe Sertoli Cell Complement Signature: A Suspected Mechanism in Xenograft Survival
Washburn, R. L., Martinez‐Marin, D., Korać, K., Sniegowski, T., Rodriguez, A. R., Chilton, B. S., Hibler, T., Pruitt, K., Bhutia, Y. D., & Dufour, J. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031890 · Cited by 14
Complement regulation in tumor immune evasion
Liu, G., He, X., Zhao, G., & Lu, Z. (2024) · Seminars in Immunology · doi:10.1016/j.smim.2024.101912 · Cited by 13
Complement cascade and kidney transplantation: The rediscovery of an ancient enemy
Mella, A., Messina, M., Lavacca, A., & Biancone, L. (2014) · World Journal of Transplantation · doi:10.5500/wjt.v4.i3.168 · Cited by 13
Scott, J., Ruchaud‐Sparagano, M., Musgrave, K. M., Roy, A. I., Wright, S. E., Perry, J. D., Morris, A. C., Rostron, A., & Simpson, A. J. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2000603 · Cited by 12
Peng, Q., Nowocin, A. K., Ratnasothy, K., Smith, R. A., Smyth, L. A., Lechler, R. I., Dorling, A., & Lombardi, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.980462 · Cited by 12
“Signaling through innate receptors such as Toll like receptors (TLRs) (36–39) and anaphylatoxin receptors (C3aR/C5aR) (26, 29) has been shown to alter the function of Tregs.”
BackgroundEllis, J. S., & Braley‐Mullen, H. (2014) · Immunology · doi:10.1111/imm.12410 · Cited by 11
Revel, M., Zarantonello, A., & Roumenina, L. T. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-85340-1_7 · Cited by 15
Cellular changes in eculizumab early responders with generalized myasthenia gravis
Li, Y., Yi, J. S., Howard, J. F., Chopra, M., Russo, M. A., & Guptill, J. T. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108830 · Cited by 10
Kalache, S., Lakhani, P., & Heeger, P. S. (2013) · Transplantation · doi:10.1097/tp.0b013e3182a77eba · Cited by 10
“In vitro suppression assays were performed as published (59).”
MethodSelf-citationSharma, A., Sudan, S. K., Vikramdeo, K. S., Khan, M. A., Tahir, M., Carter, J. E., Kendall, T., Nelson, C. L., Singh, A. P., & Singh, S. (2025) · npj Breast Cancer · doi:10.1038/s41523-025-00799-8 · Cited by 11
“The complement pathway stimulatesthe effector function of CD4 + Th1 cells and CD8 + T-cells while reducing the Treg population in tumors 67 – 69 .”
The complement system in human pregnancy and preeclampsia
Kumar, V., & Stewart, J. H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1617140 · Cited by 15
Bode, M., Herrnstadt, G. R., Dreher, L., Ehnert, N., Kirkerup, P., Lindenmeyer, M. T., Meyer‐Schwesinger, C., Ehmke, H., Köhl, J., Huber, T. B., et al. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21599 · Cited by 9
“The anaphylatoxins are known as regulators of Treg activity: C3a/C3aR and C5a/C5aR1 inhibit the function of CD4 Foxp3 circulating Tregs (Kwan et al., 2013), and absence of C3aR and C5aR1 signals in CD4 T cells induces spontaneous Foxp3 Treg differentiation upon T cells activation (Kwan et al.”
BackgroundInfluentialEffect of a C5a receptor antagonist on macrophage function in an intestinal transplant rat model
Toyama, C., Maeda, A., Kogata, S., Takase, K., Kodama, T., Masahata, K., Ueno, T., Kamiyama, M., Tazuke, Y., Eguchi, H., et al. (2022) · Transplant Immunology · doi:10.1016/j.trim.2022.101559 · Cited by 9
Role of Complement Activation in Allograft Inflammation
Chun, N. H., Horwitz, J. K., & Heeger, P. S. (2019) · Current Transplantation Reports · doi:10.1007/s40472-019-0224-2 · Cited by 9
Self-citationIntranasal peptide‐induced tolerance and linked suppression: consequences of complement deficiency
Fossati‐Jimack, L., Ling, G. S., Baudino, L., Szajna, M., Manivannan, K., Zhao, J. C., Midgley, R., Chai, J., Simpson, E., Botto, M., et al. (2014) · Immunology · doi:10.1111/imm.12358 · Cited by 8
Valero‐Hervás, D. M., Sánchez‐Zapardiel, E., Castro, M. J., Gallego‐Bustos, F., Cambra, F., Justo, I., Laguna‐Goya, R., Romero, C. J., Moreno, E., López‐Medrano, F., et al. (2016) · Clinical Transplantation · doi:10.1111/ctr.12866 · Cited by 7
Self-citationRecent advances into the role of pattern recognition receptors in transplantation
Kulkarni, H. S., Scozzi, D., & Gelman, A. E. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104088 · Cited by 7
Alexander, J. J., Chaves, L. D., Chang, A., Dighe, S. G., Jacob, A., & Quigg, R. J. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.45 · Cited by 7
Zheng, Q., Liang, S., Li, G., Lv, Y., Li, Y., Tang, M., Zhang, K., Xu, G., & Zhang, K.-Q. (2016) · Scientific Reports · doi:10.1038/srep33489 · Cited by 8
Complements from the Male Reproductive Tract: A Scoping Review
Washburn, R. L. (2024) · BioMed · doi:10.3390/biomed4010002 · Cited by 6
“Moreover, C5aR1 signaling has been shown to inhibit the immune-suppressive functions of regulatory T cells, as blocking C5aR1 signaling increased numbers of regulatory T cell numbers and enhanced their suppressive capacity [13,52].”
BackgroundMechanism and regulation of the complement activity in kidney xenotransplantation
Hirose, T., Hotta, K., Otsuka, R., & Seino, K.-I. (2025) · Transplantation Reviews · doi:10.1016/j.trre.2025.100931 · Cited by 7
Densen, P., & Ram, S. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00009-6 · Cited by 6
Signaling in T cells – is anything the m(a)TOR with the picture(s)?
Boothby, M. R. (2016) · F1000Research · doi:10.12688/f1000research.7027.1 · Cited by 6
Control of innate immunological mechanisms as a route to drug minimization
Asgari, E., Farrar, C. A., & Sacks, S. H. (2014) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000094 · Cited by 5
“Their engagement reduces expression of nTregderived FoxP3, thereby reducing their immunosuppressive capacity [12].”
Hypodermin A improves survival of skin allografts
Chen, R., Wang, Z., Yuan, H., Zhang, T.-Y., Fu, Z.-X., Hu, A., Wu, L.-L., Chen, Q., & Zhu, X.-R. (2016) · Journal of Surgical Research · doi:10.1016/j.jss.2016.03.037 · Cited by 4
Immunization of BALB/c mice with pigeon IgY induces the production of anti-IgG autoantibodies
Aranda-Uribe, I. S., Ortega, E., & Martinez-Cordero, E. (2017) · Autoimmunity · doi:10.1080/08916934.2017.1344974 · Cited by 4
“T cell activity is regulated by a subset of CD4þT cells known as regulatory T cells (Tregs) that are crucial for maintaining immunological tolerance [19].”
BackgroundInfluentialExploration of complement split products in plasma and urine as biomarkers of kidney graft rejection
Gramkow, A., Isaksson, G. L., Palarasah, Y., Jensen, B. L., Alnor, A. B., & Thiesson, H. C. (2023) · Immunobiology · doi:10.1016/j.imbio.2023.152462 · Cited by 4
Ubiquitous points of control over regulatory T cells
Pan, F., & Barbi, J. J. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1156-z · Cited by 4
Emerging roles for complement in lung transplantation
Kulkarni, H. S., Belperio, J. A., & Atkinson, C. (2025) · Journal of Clinical Investigation · doi:10.1172/jci188346 · Cited by 4
Wu, X., Qian, J., Tong, H., & Huang, X. (2025) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2025.10.014 · Cited by 3
The role of the complement system in cancer etiology and management
Sonderegger, S., Manzanero, S., Woodruff, T. M., Farouqa, J., Nabizadeh, J., Panagides, N., & Rolfe, B. E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87763-3.00012-5 · Cited by 3
Contribution of activated complements and CD59 to the pathophysiology of Rasmussen syndrome
Takahashi, Y., Nishimura, S., Takao, E., Kasai, R., Fukuoka, M., Yamaguchi, T., Araki, Y., Yonee, C., Kawano, O., Kondo, Y., et al. (2025) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2025.578667 · Cited by 3
Unveiling anaphylatoxins: Pioneering cancer therapies through complement system insights
Li, J., Li, X., Hu, J., You, Z., & Jing, Z. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189436 · Cited by 5
Blurring the Lines Between Innate and Adaptive Immunity
Chun, N. H., & Heeger, P. S. (2016) · Transplantation · doi:10.1097/tp.0000000000001429 · Cited by 3
Self-citationZheng, J., Wang, S., Tian, X., & Che, D. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11626 · Cited by 3
“c3a was initially reported to be involved in the chemotaxis, recruitment and activation of inflammatory cells by binding to the C3a receptor (C3aR) on immune cells (3-5).”
BackgroundMiyagawa, S., Kodama, T., Matsuura, R., Lo, P., Sakai, R., Toyama, C., Takama, Y., Ihara, Y., Kakuta, Y., Yamanaka, K., et al. (2021) · Transplant Immunology · doi:10.1016/j.trim.2021.101497 · Cited by 3
Ciron, C., Morice, P., Rousse, J., Roy, P., Royer, P., Gauthier, O., Brouard, S., Duvaux-Miret, O., Bassissi, F., & Vanhove, B. (2023) · JCI Insight · doi:10.1172/jci.insight.166231 · Cited by 4
“Their mechanism of action combines complement activation (complement-dependent cytotoxicity [CDC]) and cascade activation of effector T lymphocytes (21), recruitment of effector cells (antibody-dependent cellular cytotoxic [ADCC], antibody-dependent cellular phagocytosis [ADCP]), direct induction…”
BackgroundRamos, L. V. R., de Mello, M. M. B., de Melo, B. M. S., Neto, J. T. D. O., Bueno, E. K. P., Filho, J. C. F. A., Tostes, R. C., & de Castro, M. M. (2025) · Vascular Pharmacology · doi:10.1016/j.vph.2025.107523 · Cited by 2
Farshbafnadi, M., Razi, S., & Rezaei, N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-818006-8.00008-6 · Cited by 2
Role of complement in humoral immunity
Podestà, M. A., & Chun, N. H. (2023) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000001095 · Cited by 2
“Blockade of C3aR and C5aR signaling in conventional CD4þ T cells initiates TGF-b1 signaling that results in induction of regulatory T cells [24], and also augments Treg suppressive capacity [25].”
BackgroundComplement and T cell activation in transplantation
Alibrandi, S., Clemens, A., & Chun, N. H. (2024) · Transplantation Reviews · doi:10.1016/j.trre.2024.100898 · Cited by 4
He, J., Yao, Y., Wang, R., Liu, Y., Wan, X., Wang, H., Zhou, Y., Wang, W., Ma, Y., & Lv, X. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1516626 · Cited by 2
Complementing T Cells’ Functions: Bringing in Metabolism Matters
Boothby, M. R., Raybuck, A. L., & Cho, S. H. (2015) · Immunity · doi:10.1016/j.immuni.2015.06.008 · Cited by 2
“In the mouse system, the induction of FoxP3 and Treg cell characteristics were suppressed by the stimulation of the AKT limb of complement receptor signaling so that T cells doubly deficient in C3aR and C5aR facilitated mouse Treg cell generation and function (Kwan et al., 2013).”
BackgroundTriplett, A., & Hurwitz, A. A. (2014) · Cited by 2
Cui, J., Shen, F., Zhang, C., Fu, C., Zhu, J., & Zhuang, T. (2026) · Pathology - Research and Practice · doi:10.1016/j.prp.2026.156386 · Cited by 3
The role of the complement system in gastrointestinal-related diseases
Yong, B., Luo, Z., Luo, B., Liu, J., Zeng, Z., & Zheng, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1801628 · Cited by 1
“Kwan found that signaling through C3aR1 and C5aR1 reduced the inhibitory activity of CD4+CD25hiFoxp3+ Treg cells (85).”
Pal, P., Wahi, P., Paul, S., Meitei, H. T., Sahu, A., & Lal, G. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkag157 · Cited by 1
Innate immunity and hypertension: unveiling inflammatory pathways for novel therapies
Tluli, O., Abdelhamid, A., Al-Haneedi, Y., Nasrallah, D., & Eid, A. H. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1931176 · Cited by 1
Coulthard, L. G., Hawksworth, O. A., & Woodruff, T. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-810420-0.00036-5 · Cited by 1
Fageräng, B., Götz, M. P., Cyranka, L., Lau, C., Nilsson, P. H., Mollnes, T. E., & Garred, P. (2024) · Journal of Innate Immunity · doi:10.1159/000539368 · Cited by 2
Complement C3 as a Target of Host Modulation in Periodontitis
Hajishengallis, G., Kajikawa, T., Hajishengallis, E., Maekawa, T., Li, X., Belibasakis, G. N., Bostancı, N., Mastellos, D. C., Yancopoulou, D., Hastürk, H., et al. (2020) · Springer eBooks · doi:10.1007/978-3-030-42990-4_2 · Cited by 1
Immune response and histology of humoral rejection in kidney transplantation
González-Molina, M., Esteban, P. R., Caballero, A., Burgos, D., Cabello, M., Leon, M., Fuentes, L., & Hernández, D. (2016) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2016.08.002 · Cited by 6
Quality of CTL Therapies: A Changing Landscape
Thyagarajan, K., Chatterjee, S., Kesarwani, P., Nishimura, M. I., & Mehrotra, S. (2015) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-17807-3_14
“Heeger and his group have also shown that signaling through the C3aR/C5aR negatively regulates the function of Tregs [ 216 ], and thus, the use of anti-C3aR/C5aR agonistic antibody could be exploited as a therapeutic target to manipulate the functionality of Tregs so as to increase the anti-tumor CTL response.”
BackgroundA Complement to T Cell Immunity
Pekkarinen, P. T. (2014) · Työväentutkimus Vuosikirja
HIF-1alpha regulates CD55 expression in airway epithelium
Pandya, P. H. (2015)
A unified (but in fact not fully testable) model of preeclampsia triggering
Chaouat, G. (2019) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2019.03.002
Metadata
- Authors
- Kwan, W.-H., van der Touw, W., Paz-Artal, E., Li, M. O., & Heeger, P. S.
- Affiliations
- Mount Sinai Hospital (US)
- Division of Nephrology, Department of Medicine, The Immunology Institute, and the 1 2
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Heeger, Peter S.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2013-02-04
- Volume
- 210
- Issue
- 2
- Pages
- 257-268
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC3570105
- OpenAlex
- W2164578909
- Cited by
- 215
- References
- 59
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 10 · 2023: 18 · 2022: 8 · 2021: 13 · 2020: 12 · 2019: 18 · 2018: 16 · 2017: 17 · 2016: 19 · 2015: 24 · 2014: 20 · 2013: 19
- FWCI
- 15.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI043578, R01AI071185, T32AI007605)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- C5a receptor, C3a receptor, natural regulatory T cells, Foxp3 expression, complement signaling, Akt phosphorylation, FOXO1, T cell suppression, autoimmune colitis, immune tolerance
- MeSH terms
- Forkhead Box Protein O1, Animals, Autoimmune Diseases, Colitis, Graft Rejection, Immunity, Innate, Mice, Inbred BALB C, Mice, Inbred C57BL, Receptors, Complement, Recombinant Proteins, Transplantation, Homologous, Signal Transduction, Gene Expression, Skin Transplantation, Mice, Knockout, Receptor, Anaphylatoxin C5a, T-Lymphocytes, Regulatory, Proto-Oncogene Proteins c-akt, Mice, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.